Literature DB >> 10679403

Human complement regulators: a major target for pathogenic microorganisms.

G Lindahl1, U Sjöbring, E Johnsson.   

Abstract

The C3 convertases of the human complement system are controlled by fluid-phase and membrane proteins in the RCA (regulators of complement activation) family. Accumulated data show that many pathogenic microorganisms interact with these complement regulators. Recent advances in this field include determination of the crystal structure of the binding domains in the measles virus receptor CD46 and identification of a CD46 transgenic mouse line that is sensitive to measles virus. Moreover, recent findings support the hypothesis that pathogenic bacteria binding fluid-phase RCA proteins exploit these proteins to escape complement attack. These studies provide novel insight into the interplay between pathogens and the innate immune system and may have implications for the plans to use animals expressing an RCA protein for xenotransplantation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679403     DOI: 10.1016/s0952-7915(99)00049-7

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  40 in total

Review 1.  The immunopathogenesis of meningococcal disease.

Authors:  A J Kvalsvig; D J Unsworth
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

2.  Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A.

Authors:  Sunil K Sukumaran; Hiroyuki Shimada; Nemani V Prasadarao
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3.

Authors:  Dominique Sirena; Benjamin Lilienfeld; Markus Eisenhut; Stefan Kälin; Karin Boucke; Roger R Beerli; Lorenz Vogt; Christiane Ruedl; Martin F Bachmann; Urs F Greber; Silvio Hemmi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Letter to the Editor: Resonance assignments of the central complement control protein module pair of human decay accelerating factor.

Authors:  Stanislava Uhrínová; Feng Lin; Du Usan Uhrín; M Edward Medof; Paul N Barlow
Journal:  J Biomol NMR       Date:  2002-06       Impact factor: 2.835

5.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

6.  Hydrophilic domain II of Escherichia coli Dr fimbriae facilitates cell invasion.

Authors:  Margaret Das; Audrey Hart-Van Tassell; Petri T Urvil; Susan Lea; David Pettigrew; K L Anderson; Alfred Samet; Jozef Kur; Steve Matthews; Stella Nowicki; Vsevolod Popov; Pawel Goluszko; Bogdan J Nowicki
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

7.  The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35.

Authors:  Christoph Fleischli; Sandra Verhaagh; Menzo Havenga; Dominique Sirena; Walter Schaffner; Roberto Cattaneo; Urs F Greber; Silvio Hemmi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  LfhA, a novel factor H-binding protein of Leptospira interrogans.

Authors:  Ashutosh Verma; Jens Hellwage; Sergey Artiushin; Peter F Zipfel; Peter Kraiczy; John F Timoney; Brian Stevenson
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

9.  Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides.

Authors:  Anna E Engberg; Kerstin Sandholm; Fredrik Bexborn; Jenny Persson; Bo Nilsson; Gunnar Lindahl; Kristina N Ekdahl
Journal:  Biomaterials       Date:  2009-01-25       Impact factor: 12.479

10.  Role of Supramolecule ErpY-Like Lipoprotein of Leptospira in Thrombin-Catalyzed Fibrin Clot Inhibition and Binding to Complement Factors H and I, and Its Diagnostic Potential.

Authors:  Karukriti Kaushik Ghosh; Aman Prakash; Anusua Dhara; Md Saddam Hussain; Prateek Shrivastav; Pankaj Kumar; Vinayagamurthy Balamurugan; Manish Kumar
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.